Skip to main content
Clinical Trials/JPRN-UMIN000045447
JPRN-UMIN000045447
Recruiting
未知

Retrospective study about the prognosis in patients with non-valvular atrial fibrillation who underwent a percutaneous left atrial appendage closure. - Retrospective study about left atrial appendage closure device

Department of Cardiology, Kokura Memorial Hospital0 sites100 target enrollmentSeptember 10, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
onvalvular atrial fibrillation
Sponsor
Department of Cardiology, Kokura Memorial Hospital
Enrollment
100
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 10, 2021
End Date
September 2, 2031
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Department of Cardiology, Kokura Memorial Hospital

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\. patients requiring long\-term use of oral anticoagulants for reasons other than non\-valvular atrial fibrillation (e.g., patients with implanted mechanical prosthetic valves, patients with hypercoagulable states, or patients with recurrent DVT) 2\. patients with evidence of intracardiac (especially intra\-atrial) thrombus. 3\. patients with atrial septal defect or foramen ovale repair (surgery, device implantation, etc.), or patients with atrial septal defect or foramen ovale repair (surgery, device implantation, etc.). Patients with a history of atrial septal defect or atrial septal suture closure. 4\. patients with anatomical structures of the left ventricular ear that are not amenable to closure devices. 5\. patients with contraindications to left ventricular closure (transesophageal echocardiography (TEE)) or patients with contraindications to left ventricular closure (e.g., difficulty in inserting transesophageal echocardiography (TEE) probe or catheter required for the procedure). 6\. patients with contraindications to anticoagulation, aspirin, or thienopyridine.

Outcomes

Primary Outcomes

Not specified

Similar Trials